Al-Razi Medical Company (TADAWUL:9572)

Al-Razi Medical Company Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.29	0.31	0.77	0.85	1.53	7.79
Cash & Short-Term Investments	0.29	0.31	0.77	0.85	1.53	7.79
Cash Growth	-2.01%	-59.26%	-9.82%	-44.31%	-80.39%	-
Accounts Receivable	2.92	4.42	2.15	0.84	0.83	1.62
Other Receivables	-	0.01	0.06	0.25	-	-
Receivables	2.92	4.43	2.21	1.09	0.83	1.62
Inventory	21.35	23.64	18.32	22	22.43	17.12
Prepaid Expenses	0.95	0.4	0.36	0.76	0.94	-
Other Current Assets	-	0.56	0.48	0.9	0.63	0.89
Total Current Assets	25.51	29.34	22.15	25.59	26.35	27.42
Property, Plant & Equipment	23.53	23.79	18.38	19.35	16.22	12.55
Other Intangible Assets	0.14	0.2	0.34	0.47	0.26	0.06
Total Assets	49.18	53.33	40.86	45.42	42.84	40.03

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	12.62	16.08	7.82	10.54	9.95	8.14
Accrued Expenses	0.36	0.33	0.25	0.24	0.35	0.04
Current Portion of Long-Term Debt	1.25	1.75	1.94	0.93	-	0.75
Current Portion of Leases	1.74	1.53	1.12	2.16	2.01	1.17
Current Income Taxes Payable	0.14	0.25	0.35	0.4	0.41	0.37
Current Unearned Revenue	-	0.03	0.03	-	0.04	0.06
Other Current Liabilities	-	0	-	0.03	-	-
Total Current Liabilities	16.1	19.98	11.52	14.29	12.76	10.52
Long-Term Debt	0.47	1.02	2.77	1.78	-	-
Long-Term Leases	7.37	7.63	2.81	5.83	5.61	4.67
Pension & Post-Retirement Benefits	1.31	1.21	1.15	1.16	0.88	0.64
Total Liabilities	25.26	29.83	18.24	23.05	19.24	15.83

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	15.2	15.2	15.2	15.2	15.2	15.2
Additional Paid-In Capital	6.7	6.7	6.7	6.7	6.18	6.85
Retained Earnings	2	1.58	0.76	0.59	2.31	2.19
Comprehensive Income & Other	0.02	0.02	-0.04	-0.11	-0.1	-0.04
Shareholders' Equity	23.92	23.5	22.62	22.37	23.59	24.2
Total Liabilities & Equity	49.18	53.33	40.86	45.42	42.84	40.03

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	10.84	11.92	8.64	10.69	7.62	6.58
Net Cash (Debt)	-10.54	-11.61	-7.87	-9.84	-6.09	1.21
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-6.94	-7.64	-5.18	-6.47	-4.01	0.79
Filing Date Shares Outstanding	1.52	1.52	1.52	1.52	1.52	1.52
Total Common Shares Outstanding	1.52	1.52	1.52	1.52	1.52	1.52
Working Capital	9.41	9.36	10.63	11.3	13.6	16.9
Book Value Per Share	15.74	15.46	14.88	14.72	15.52	15.92
Tangible Book Value	23.78	23.3	22.28	21.9	23.33	24.14
Tangible Book Value Per Share	15.64	15.33	14.66	14.40	15.35	15.88
Land	2.75	2.75	2.75	2.5	-	-
Buildings	4.02	3.29	3.25	6.91	6.07	5.46
Machinery	9.34	8.75	7.68	6.93	6.56	4.24
Construction In Progress	0.79	1.39	0.57	1.07	0.05	0.28
Leasehold Improvements	6.94	6.94	6.92	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 15, 2026

Data Sources Report a data error